For instance, in neuroblastoma, downregulation of TRAIL receptors as a result of promoter hypermethylation was shown to decrease the response and sensitivity to TRAIL ligand, thus weakening the downstream apoptosis signaling [57,58]. The gene discussed is TNFSF10; the disease is neuroblastoma.